Atif Ghaffar
General Practice · New Orleans, LANPI 1679159107
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 94 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. Among general practice clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 94 payments — averaging $43.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EMD Serono, Inc.$592
- UCB, Inc.$526
- Neurelis, Inc.$475
- SK Life Science, Inc.$309
- AbbVie$309
- CSL Behring$257
- plus $2K from 14 others
What the payments were for
- Food & beverage$3,99899%
- Education$551%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| EMD Serono, Inc. | 8 | $592 |
| UCB, Inc. | 15 | $526 |
| Neurelis, Inc. | 16 | $475 |
| SK Life Science, Inc. | 9 | $309 |
| AbbVie | 9 | $309 |
| CSL Behring | 7 | $257 |
| Teva Pharmaceuticals USA, Inc. | 3 | $252 |
| AstraZeneca(2 entities) | 3 | $244 |
| Sanofi | 2 | $241 |
| Eisai Inc. | 9 | $185 |
| Amgen | 2 | $140 |
| Argenx US, Inc. | 1 | $115 |
| Kyowa Kirin, Inc. | 1 | $95 |
| Johnson & Johnson | 1 | $77 |
| Octapharma USA, Inc. | 2 | $70 |
| Ipsen Biopharmaceuticals, Inc | 1 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| Biogen | 2 | $30 |
| Sarepta Therapeutics, Inc. | 1 | $30 |
| Jazz Pharmaceuticals Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,053 in reported general payments places this provider in the 95th percentile of 1,221 general practice providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aimovig AutoinjectorErenumab-Aooe | 11 | $8,521 |
| Dalfampridine ErDalfampridine | 13 | $4,407 |
| Levetiracetam | 25 | $700 |
| Divalproex Sodium ErDivalproex Sodium | 13 | $601 |
| Gabapentin | 30 | $439 |
| Phenobarbital | 12 | $426 |
| Valproic AcidValproic Acid (As Sodium Salt) | 12 | $185 |
| Baclofen | 13 | $152 |
| Topiramate | 14 | $146 |
| Clonazepam | 25 | $67 |
Paid to pharmacies, not to this prescriber.
Other general practice in New Orleans
- Roboan Guillen ArguelloNew Orleans$7K
- Jonah MooreNew Orleans$6K
- Charles BoudreauxNew Orleans$6K
- Mark ChaneyNew Orleans$4K
- Robert CamenzuliNew Orleans$4K
- William CaldwellMetairie$943K
- William MaloneLafayette$46K
- Muhammad AnjumShreveport$33K
- Melissa RatliffBarksdale Afb$22K
- Louis PassauerMandeville$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.